Enanta Pharmaceuticals (ENTA) Minority Interest (2014 - 2015)

Enanta Pharmaceuticals (ENTA) reported Minority Interest of $164000.0 for Q4 2015, up 0.61% quarter-over-quarter from $163000.0 in Q3 2015.

Enanta Pharmaceuticals (ENTA) Minority Interest (2014 - 2015) Analysis & Trends

Enanta Pharmaceuticals has reported Minority Interest for 2 years, with the latest figure at $164000.0 in Q4 2015.

For the quarter ending Q4 2015, Minority Interest changed N/A year-over-year to $164000.0; the trailing twelve-month figure through Dec 2015 stood at $164000.0 (changed N/A YoY), and the FY2015 full-year result was $163000.0, down 19.31% from the prior year.
Minority Interest for Q4 2015 stood at $164000.0, up from $163000.0 in the prior quarter.
The five-year high for Minority Interest was $202000.0 in Q3 2014, with the low at $163000.0 in Q3 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Enanta Pharmaceuticals	365.48 Mn	201.71 Mn	-

Download Data